Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions
暂无分享,去创建一个
D. Lewis | B. Lake | B G Lake | D F V Lewis
[1] R. Lindberg,et al. Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue , 1989, Nature.
[2] D. Lewis,et al. The CYP2 family: models, mutants and interactions. , 1998, Xenobiotica; the fate of foreign compounds in biological systems.
[3] D E McRee,et al. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. , 2000, Molecular cell.
[4] M H Tarbit,et al. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity. , 1999, Toxicology.
[5] D. Lewis,et al. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[6] T. Darden,et al. Structural flexibility and functional versatility of cytochrome P450 and rapid evolution. , 1996, Mutation research.
[7] O. Gotoh,et al. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. , 1992, The Journal of biological chemistry.
[8] B. Lake,et al. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment. , 1999, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[9] B C Finzel,et al. Crystal structure of substrate-free Pseudomonas putida cytochrome P-450. , 1986, Biochemistry.
[10] M. Dickins,et al. Quantitative Structure-Activity Relationships (QSARs) Within Substrates of Human Cytochromes P450 Involved in Drug Metabolism , 2001, Drug metabolism and drug interactions.
[11] S. Born,et al. In vitro kinetics of coumarin 3,4-epoxidation: application to species differences in toxicity and carcinogenicity. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.
[12] Yoshihiro Kudo,et al. Automatic log P estimation based on combined additive modeling methods , 1990, J. Comput. Aided Mol. Des..
[13] M. Negishi,et al. Structural function of residue-209 in coumarin 7-hydroxylase (P450coh). Enzyme-kinetic studies and site-directed mutagenesis. , 1991, The Journal of biological chemistry.
[14] Slobodan Petar Rendic,et al. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. , 1997, Drug metabolism reviews.
[15] D. Lewis,et al. Factors influencing rates and clearance in P450-mediated reactions: QSARs for substrates of the xenobiotic-metabolizing hepatic microsomal P450s. , 2002, Toxicology.
[16] K. Korzekwa,et al. Site-directed mutagenesis of cytochrome P450s CYP2A1 and CYP2A2: influence of the distal helix on the kinetics of testosterone hydroxylation. , 1992, Biochemistry.
[17] T. Poulos,et al. High-resolution crystal structure of cytochrome P450cam. , 1987, Journal of molecular biology.
[18] Ş. Şardaş,et al. Dtermination of coumarin metabolism in Turkish population , 2001, Human & experimental toxicology.
[19] J Deisenhofer,et al. Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. , 1993, Science.
[20] D. Lewis,et al. Molecular modelling of members of the P4502A subfamily: application to studies of enzyme specificity. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.
[21] O. Pelkonen,et al. CYP2A6: a human coumarin 7-hydroxylase. , 2000, Toxicology.
[22] S. Born,et al. Synthesis and reactivity of coumarin 3,4-epoxide. , 1997, Drug metabolism and disposition: the biological fate of chemicals.
[23] T. Poulos,et al. The structure of the cytochrome p450BM-3 haem domain complexed with the fatty acid substrate, palmitoleic acid , 1997, Nature Structural Biology.